Anzeige
Mehr »
Login
Samstag, 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QR4M | ISIN: FI4000490875 | Ticker-Symbol: 7XE
München
22.11.24
08:13 Uhr
2,860 Euro
-0,130
-4,35 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NIGHTINGALE HEALTH OYJ Chart 1 Jahr
5-Tage-Chart
NIGHTINGALE HEALTH OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
2,7302,89013:04

Aktuelle News zur NIGHTINGALE HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.11.Nightingale Health Asia achieves ISO 13485:2016 certification and completes regulatory readiness to launch its blood testing service in Singapore2
08.11.Resolutions of the Annual General Meeting and the Board of Directors' organizational meeting of Nightingale Health Plc3
06.11.Renowned international expert in medicine Dr. Charles Alessi joins Nightingale Health UK as Chief Medical Officer2
30.10.Nightingale Health and Boston Heart Diagnostics have successfully completed their pilot and move to the production phase expanding the use of Nightingale's Health Check in the US1
10.10.Notice to the Annual General Meeting of Nightingale Health Plc1
10.10.Nightingale Health's Annual Report for financial year 2023-2024 has been published1
09.10.Conversion of Nightingale Health Plc's Series A shares to Series B shares1
NIGHTINGALE HEALTH Aktie jetzt für 0€ handeln
20.09.Nightingale Health's Board of Directors resolved on amendment to CEO's incentive program1
20.09.Nightingale Health Oyj: Nightingale Health Plc Financial Statements Release 1 July 2023 - 30 June 202470Nightingale Health Plc Company release 20 September 2024 at 9:00 a.m. (EEST)Nightingale Health Group's Financial Statements Release 1 July 2023 - 30 June 2024 (unaudited) Nightingale's Financial Statements...
► Artikel lesen
19.09.Nightingale Health receives third regulatory approval for healthcare use from Health Sciences Authority in Singapore1
05.09.Nightingale Health to publish Financial Statements Release for financial year July 2023 - June 2024 on 20 September 20241
20.08.Nightingale Health attains UKCA marking for its blood analysis technology to bring its technology to healthcare use in the United Kingdom1
20.08.Nightingale Health receives additional regulatory approval for healthcare use from Health Sciences Authority in Singapore1
06.08.Nightingale Health and U.S.-based Phenome Health announce a partnership to strive towards the most transformational change in the history of healthcare1
04.07.Nightingale Health Plc - Managers' transactions - Olli Karhi1
03.07.Summary of Financial Year 7/2023 - 6/2024: Nightingale Health achieved several breakthroughs in adopting the company's technology in healthcare2
28.06.Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel4
28.06.23andMe, Inc.: 23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel149SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker...
► Artikel lesen
28.06.Inside information: Nightingale Health and Boston Heart Diagnostics enter strategic partnership to sell Nightingale's Health Check in the United States1
27.06.Nightingale Health and ZOE expand research collaboration to include self-collected blood samples1
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1